REVELATION BIOSCIENCES, INC. Increase (Decrease) in Prepaid Expense
REVELATION BIOSCIENCES, INC. (REVB) reported Increase (Decrease) in Prepaid Expense of -$109.44 thousand for the 12-month period ending 2021-12-31, per its 10-K filed 2022-04-15.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidExpense · last filed 2022-04-15
- REVELATION BIOSCIENCES, INC. increase (decrease) in prepaid expense for the quarter ending 2021-03-31 was $10.24K.
- REVELATION BIOSCIENCES, INC. increase (decrease) in prepaid expense for fiscal 2021 was -$109.44K, a 195.77% decline from fiscal 2020.
- REVELATION BIOSCIENCES, INC. increase (decrease) in prepaid expense for fiscal 2020 was $114.27K.
| Period end | Increase (Decrease) in Prepaid Expense 3 month | Increase (Decrease) in Prepaid Expense 12 month |
|---|---|---|
| 2021-12-31 | -$109.44K 10-K · filed 2022-04-15 | |
| 2021-03-31 | $10.24K 10-Q · filed 2021-06-22 | |
| 2020-12-31 | $114.27K 10-K · filed 2022-04-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |